In addition, BM monocytes from MM patients expressed CX3CR1, and, in particular, the subset CD14+CD16+ showed a higher expression of the receptor as compared to the CD14+CD16− one (P = 0.0055, Mann–Whitney test) evaluated as median fluorescence intensity (MFI) by flow cytometry (Figure 5B,C). The gene discussed is CX3CR1; the disease is Miyoshi myopathy.